three years of small molecule threads, summarised so you do not have to read them
three years of small molecule threads, summarised so you do not have to read them. Change my mind, genuinely — I have no stake in being right about this. Analytically this is a small-molecule identity and purity problem, not a peptide one. The methods, the impurity classes and the reference standards are all…
a non-peptide agonist does not degrade the way a peptide does
Spent an evening reading about small-molecule agonism at a peptide receptor. Genuinely interesting engineering.
nothing containing this is approved anywhere yet
phase 3 is where the comparison becomes fair
It is a non-peptide small-molecule agonist at the GLP-1 receptor. That is a substantial medicinal chemistry achievement: getting a small molecule to activate a receptor evolved for a peptide ligand.
Assumed the peptide purity conversations transferred and they do not. Different analytical problem entirely.